Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.42 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.42 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL45197 | 0.93 | — | — | |
| SCHEMBL5905762 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| SCHEMBL5080081 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| Ammonia Solution, Strong SCHEMBL10355456 | 0.90 | TDP1 (0.50) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| SCHEMBL5144811 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| SCHEMBL1100230 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| SCHEMBL5144412 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| SCHEMBL5905658 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| SCHEMBL5165804 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 | |
| SCHEMBL28174672 | 0.90 | SLC22A6 (0.45) | SLC22A6TDP1SMN1; SMN2CACNA2D1CACNB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-119999825-A | Application of squid freeze-dried powder, feed and shrimp culturing method | 海南大学 | 2025-05-16 | — | — | CN | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| CN-116381101-A | Urine metabolism small molecule for assisting in diagnosing embryo planting success rate and application thereof | 南京医科大学 | 2023-07-04 | — | — | CN | claimed |
| WO-2023077166-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC (US) | 2023-05-04 | — | — | WO | claimed |
| US-20230137741-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC | 2023-05-04 | — | — | US | claimed |
| WO-2017189528-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | Ecolab USA, Inc. (US) | 2017-11-02 | — | — | WO | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| US-8608922-B2 | Biosensor for continuous monitoring of metabolites and proteins and methods of manufacture thereof | THE UNIVERSITY OF CONNECTICUT (US) | 2013-12-17 | — | — | US | claimed |
| US-20100116691-A1 | BIOSENSOR FOR CONTINUOUS MONITORING OF METABOLITES AND PROTEINS AND METHODS OF MANUFACTURE THEREOF | UNIVERSITY OF CONNECTICUT (US) | 2010-05-13 | — | — | US | claimed |
| US-20090197845-A1 | Method for treating olfactory disorder | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION SAMSUNG MEDICAL CENTER (KR) | 2009-08-06 | — | — | US | claimed |
| US-20080125405-A1 | Composition for treating or preventing olfactory disorder | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION SAMSUNG MEDICAL CENTER (KR) | 2008-05-29 | — | — | US | claimed |
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | MATTERWORKS INC (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-20090197845-A1 | Method for treating olfactory disorder | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION SAMSUNG MEDICAL CENTER (KR) | 2009-08-06 | — | — | US | disclosed |
| US-20090197845-A1 | Method for treating olfactory disorder | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION SAMSUNG MEDICAL CENTER (KR) | 2009-08-06 | — | — | US | disclosed |
| US-20080125405-A1 | Composition for treating or preventing olfactory disorder | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION SAMSUNG MEDICAL CENTER (KR) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | SRMS, PTMS, CALCB | SLC22A6 560/4885TDP1 4693/4885SMN1; SMN2 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.